Bioqual (OTCMKTS:BIOQ) Releases Earnings Results

Bioqual (OTCMKTS:BIOQ) issued its earnings results on Monday. The company reported $0.31 earnings per share (EPS) for the quarter, reports. Bioqual had a net margin of 1.51% and a return on equity of 2.48%. The business had revenue of $15.34 million for the quarter.

Bioqual Stock Performance

Bioqual stock remained flat at $75.00 during trading hours on Wednesday. 35 shares of the company’s stock traded hands, compared to its average volume of 33. The company’s fifty day moving average is $75.68 and its two-hundred day moving average is $69.29. Bioqual has a 1 year low of $59.00 and a 1 year high of $82.00.

About Bioqual

Bioqual, Inc provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer.